Literature DB >> 30597196

The LMTK-family of kinases: Emerging important players in cell physiology and pathogenesis.

Franz Wendler1, Teodora-Maria Purice2, Thomas Simon2, Justin Stebbing3, Georgios Giamas4.   

Abstract

Lemur Tail (former tyrosine) Kinases (LMTKs) comprise a novel family of regulated serine/threonine specific kinases with three structurally and evolutionary related members. LMTKs exercise a confusing variety of cytosolic functions in cell signalling and membrane trafficking. Moreover, LMTK2 and LMTK3 also reside in the nucleus where they participate in gene transcription/regulation. As a consequence, LMTKs impact cell proliferation and apoptosis, cell growth and differentiation, as well as cell migration. All these fundamental cell behaviours can turn awry, most prominently during neuropathologies and tumour biogenesis. In cancer cells, LMTK levels are often correlated with poor overall prognosis and therapy outcome, not least owned to acquired drug resistance. In brain tissue, LMTKs are highly expressed and have been linked to neuronal and glia cell differentiation and cell homeostasis. For one member of the LMTK-family (LMTK2) a role in cystic fibrosis has been identified. Due to their role in fundamental cell processes, altered LMTK physiology may also warrant a hitherto unappreciated role in other diseases, and expose them as potential valuable drug targets. On the backdrop of a compendium of LMTK cell functions, we hypothesize that the primary role of LMTKs may dwell within the endocytic cargo recycling and/or nuclear receptor transport pathways.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Cancer; Channels; Cystic fibrosis; Endocytic recycling; Kinases; Membrane trafficking; Neurodegenerative disease; Sex steroid hormones

Year:  2018        PMID: 30597196     DOI: 10.1016/j.bbadis.2018.12.023

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  8 in total

1.  LMTK2 regulates inflammation in lipopolysaccharide-stimulated BV2 cells.

Authors:  Qianyun Rui; Shugang Cao; Xiaozhu Wang; Xiaoyu Duan; Xinyi Iao; Wanli Dong; Qi Fang; Xueguang Zhang; Qun Xue
Journal:  Exp Ther Med       Date:  2021-01-18       Impact factor: 2.447

Review 2.  Receptor tyrosine kinase activation: From the ligand perspective.

Authors:  Raphael Trenker; Natalia Jura
Journal:  Curr Opin Cell Biol       Date:  2020-02-27       Impact factor: 8.382

3.  LMTK1, a Novel Modulator of Endosomal Trafficking in Neurons.

Authors:  Shin-Ichi Hisanaga; Ran Wei; Anni Huo; Mineko Tomomura
Journal:  Front Mol Neurosci       Date:  2020-06-30       Impact factor: 5.639

4.  LMTK2 binds to kinesin light chains to mediate anterograde axonal transport of cdk5/p35 and LMTK2 levels are reduced in Alzheimer's disease brains.

Authors:  Gábor M Mórotz; Elizabeth B Glennon; Patricia Gomez-Suaga; Dawn H W Lau; Eleanor D Robinson; Éva Sedlák; Alessio Vagnoni; Wendy Noble; Christopher C J Miller
Journal:  Acta Neuropathol Commun       Date:  2019-05-08       Impact factor: 7.801

Review 5.  Expanding the Disorder-Function Paradigm in the C-Terminal Tails of Erbbs.

Authors:  Louise Pinet; Nadine Assrir; Carine van Heijenoort
Journal:  Biomolecules       Date:  2021-11-14

6.  Proximity Profiling of the CFTR Interaction Landscape in Response to Orkambi.

Authors:  Melissa Iazzi; Audrey Astori; Jonathan St-Germain; Brian Raught; Gagan D Gupta
Journal:  Int J Mol Sci       Date:  2022-02-23       Impact factor: 5.923

7.  Physical and functional interactome atlas of human receptor tyrosine kinases.

Authors:  Xiaonan Liu; Tiina Öhman; Kari Salokas; Iftekhar Chowdhury; Lisa Gawriyski; Salla Keskitalo; Markku Varjosalo
Journal:  EMBO Rep       Date:  2022-04-05       Impact factor: 9.071

Review 8.  Lemur Tyrosine Kinases and Prostate Cancer: A Literature Review.

Authors:  Elena Ferrari; Valeria Naponelli; Saverio Bettuzzi
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.